NYXH gained a finalized CMS rule assigning CPT 64568 to New Technology APC 1580 for Genio implants. The change boosts NYXH's 2026 reimbursement to about $45,000 in outpatient and $42,373 in ASC ...
Hosted on MSN
Nyxoah’s Genio therapy gets significant 2026 Medicare reimbursement increases under final CMS rule
Nyxoah SA (NYXH) said Wednesday that Medicare reimbursement for its Genio hypoglossal nerve stimulation therapy will rise sharply in 2026, with Hospital Outpatient Department payments for CPT 64568 ...
Big news for anyone concerned about reimbursement issues for wireless health: CardioNet, which leverages wireless technology to diagnose and monitor cardiac arrhythmias, announced this week that the ...
WASHINGTON, DC, DC, UNITED STATES, March 19, 2026 /EINPresswire.com/ — The Physical Activity Alliance (PAA) is urging health systems and physician groups nationwide ...
Nyxoah NYXH recently announced that the CY2026 Hospital Outpatient Prospective Payment System (“HOPPS”) and Ambulatory Surgery Center (“ASC”) Rule has been finalized by the U.S. Centers for Medicare & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results